July 7 (Reuters) - Medicure Inc MPH.V
* Medicure receives response letter from FDA on aggrastat
SNDA for new indication
* Received a complete response letter from U.S. Food and
Drug Administration (FDA) for its supplemental new drug
application
* FDA does not approve application in its present form
Source text for Eikon: ID:nPn4Lqwg4a
Further company coverage: MPH.V
(Bengaluru Newsroom: +1-646-223-8780)